- Home
- SUZ vs NBIX Comparison
SUZ vs NBIX Comparison
Compare SUZ & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUZ | NBIX |
|---|---|---|
| Founded | 1924 | 1992 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 14.4B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SUZ | NBIX |
|---|---|---|
| Price | $9.27 | $155.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $173.79 |
| AVG Volume (30 Days) | ★ 2.6M | 969.9K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ 61.72 | 12.44 |
| EPS | 0.99 | ★ 4.19 |
| Revenue | ★ $9,603,137,110.00 | $2,682,700,000.00 |
| Revenue This Year | $7.22 | $23.76 |
| Revenue Next Year | $13.64 | $18.01 |
| P/E Ratio | ★ $9.37 | $37.10 |
| Revenue Growth | 17.39 | ★ 19.61 |
| 52 Week Low | $8.41 | $84.23 |
| 52 Week High | $10.98 | $157.67 |
Technical Indicators
Market Signals| Indicator | SUZ | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 64.81 |
| Support Level | $8.86 | $150.26 |
| Resistance Level | $9.06 | $154.35 |
| Average True Range (ATR) | 0.13 | 4.16 |
| MACD | 0.04 | 1.07 |
| Stochastic Oscillator | 73.44 | 93.25 |
Price Performance
Historical ComparisonAbout SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.